These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 8357185)

  • 1. Regulation of experimental autoimmune myasthenia gravis by synthetic peptides of the acetylcholine receptor.
    Souroujon MC; Carmon S; Fuchs S
    Ann N Y Acad Sci; 1993 Jun; 681():332-4. PubMed ID: 8357185
    [No Abstract]   [Full Text] [Related]  

  • 2. Differences between the epsilon and gamma subunits of the acetylcholine receptor (AChR) may be significant in autoimmune myasthenia gravis.
    Ragheb S; Lisak RP
    Ann N Y Acad Sci; 2003 Sep; 998():336-8. PubMed ID: 14592892
    [No Abstract]   [Full Text] [Related]  

  • 3. Myasthenia gravis: nicotinic acetylcholine receptors as targets for autoimmune attack.
    Newsom-Davis J; Harcourt G; Beeson D
    Biochem Soc Trans; 1989 Aug; 17(4):635-7. PubMed ID: 2670631
    [No Abstract]   [Full Text] [Related]  

  • 4. Stimulation of autoimmune helper T lymphocytes from patients with myasthenia gravis with synthetic peptides of the acetylcholine receptor alpha subunit.
    Hohlfeld R; Toyka KV; Miner LL; Conti-Tronconi BM
    Ann N Y Acad Sci; 1988; 540():511-2. PubMed ID: 2462826
    [No Abstract]   [Full Text] [Related]  

  • 5. Determinant selection in murine experimental autoimmune myasthenia gravis. Effect of the bm12 mutation on T cell recognition of acetylcholine receptor epitopes.
    Infante AJ; Thompson PA; Krolick KA; Wall KA
    J Immunol; 1991 May; 146(9):2977-82. PubMed ID: 1707927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An immunogenic self-peptide for T cells in mice with experimental myasthenia.
    Xu Q; Agius M; Gudipati E; Fairclough RH; Richman DP
    Ann N Y Acad Sci; 1993 Jun; 681():1-4. PubMed ID: 8357155
    [No Abstract]   [Full Text] [Related]  

  • 7. The role of acetylcholine receptor antibodies in myasthenia gravis.
    Appel SH; Elias SB; Chauvin P
    Fed Proc; 1979 Sep; 38(10):2381-5. PubMed ID: 478014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epitope-specific suppression of antibody response in experimental autoimmune myasthenia gravis by a monomethoxypolyethylene glycol conjugate of a myasthenogenic synthetic peptide.
    Atassi MZ; Ruan KH; Jinnai K; Oshima M; Ashizawa T
    Proc Natl Acad Sci U S A; 1992 Jul; 89(13):5852-6. PubMed ID: 1378618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experimental myasthenia gravis in congenic mice. Sequence mapping and H-2 restriction of T helper epitopes on the alpha subunits of Torpedo californica and murine acetylcholine receptors.
    Bellone M; Ostlie N; Lei S; Conti-Tronconi BM
    Eur J Immunol; 1991 Oct; 21(10):2303-10. PubMed ID: 1680694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experimental myasthenia gravis is inhibited by receptor-antireceptor complexes.
    Barkas T; Simpson JA
    J Clin Lab Immunol; 1982 Apr; 7(3):223-7. PubMed ID: 7097749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EAMG induced in rabbits by immunization against peptides representing human AChR alpha 138-199.
    Jacobson L; Vincent A; Shillito P; Newsom-Davis J
    Ann N Y Acad Sci; 1993 Jun; 681():295-7. PubMed ID: 8357174
    [No Abstract]   [Full Text] [Related]  

  • 12. Human acetylcholine receptor presentation in myasthenia gravis. DR restriction of autoimmune T epitopes and binding of synthetic receptor sequences to DR molecules.
    Manfredi AA; Yuen MH; Moiola L; Protti MP; Conti-Tronconi BM
    J Immunol; 1994 Apr; 152(8):4165-74. PubMed ID: 7511671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular anatomy of an autoantigen: T and B epitopes on the nicotinic acetylcholine receptor in myasthenia gravis.
    Manfredi AA; Protti MP; Bellone M; Moiola L; Conti-Tronconi BM
    J Lab Clin Med; 1992 Jul; 120(1):13-21. PubMed ID: 1377215
    [No Abstract]   [Full Text] [Related]  

  • 14. Proliferative responses to acetylcholine receptor peptides in myasthenia gravis.
    Berrih-Aknin S; Cohen-Kaminsky S; Neumann D; Bach JF; Fuchs S
    Ann N Y Acad Sci; 1988; 540():504-5. PubMed ID: 2462824
    [No Abstract]   [Full Text] [Related]  

  • 15. Antigenic structure of the muscle nicotinic acetylcholine receptor.
    Tzartos SJ; Cung MT; Mamalaki A; Marraud M; Papanastasiou D; Sakarellos C; Sakarellos-Daitsiotis M; Tsantili P
    Ann Med Interne (Paris); 1996; 147(6):442-6. PubMed ID: 9092347
    [No Abstract]   [Full Text] [Related]  

  • 16. Stereo view of conformation and myasthenogenicity in synthetic peptides of acetylcholine receptor alpha-subunit.
    Takamori M
    Ann N Y Acad Sci; 1993 Jun; 681():168-71. PubMed ID: 8357163
    [No Abstract]   [Full Text] [Related]  

  • 17. Molecular and antigenic structure of nicotinic acetylcholine receptors.
    Lindstrom J; Peng X; Kuryatov A; Lee E; Anand R; Gerzanich V; Wang F; Wells G; Nelson M
    Ann N Y Acad Sci; 1998 May; 841():71-86. PubMed ID: 9668222
    [No Abstract]   [Full Text] [Related]  

  • 18. Synthetic peptide of human acetylcholine receptor alpha-subunit sequence 125-147 (methionine 144), a more potent autoantigen than its norleucine 144 analog.
    Lennon VA; Huang ZX; McCormick DJ; Griesmann GE; Fujii N; Lambert EH
    Ann N Y Acad Sci; 1988; 540():516-9. PubMed ID: 2462827
    [No Abstract]   [Full Text] [Related]  

  • 19. Myasthenia gravis: recognition of a human autoantigen at the molecular level.
    Protti MP; Manfredi AA; Horton RM; Bellone M; Conti-Tronconi BM
    Immunol Today; 1993 Jul; 14(7):363-8. PubMed ID: 8363727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autoimmune diseases involving nicotinic receptors.
    Lindstrom J
    J Neurobiol; 2002 Dec; 53(4):656-65. PubMed ID: 12436428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.